Obstructive Sleep Apnea (OSA): The Partner and Family Role
How partners and family members can recognize OSA symptoms, support CPAP adherence, encourage weight-loss treatment, and help a loved one get diagnosed and stay on track.
Obstructive Sleep Apnea (OSA): When to Seek a Second Opinion
A guide on obstructive sleep apnea covering diagnosis, treatment options including Zepbound, CPAP, and surgery, plus clear signals that your care plan warrants a second opinion.
PCOS Treatment: How to Stop Safely and What Happens When You Do
A guide to stopping PCOS treatments safely, including metformin, GLP-1 receptor agonists, oral contraceptives, and spironolactone. Covers withdrawal effects, rebound risks, and how to taper each medication class.
PCOS First-Line Treatment Decision Framework
A decision framework for first-line PCOS management covering lifestyle, metformin, hormonal contraception, and GLP-1 receptor agonists, with citations from Endocrine Society, ADA, and primary trial data.
PCOS (Polycystic Ovary Syndrome): How to Prep for Your First Visit
A complete guide to preparing for your first PCOS appointment, what labs to request, what symptoms to track, how GLP-1s and lifestyle changes fit in, and what questions to bring.
PCOS Commonly Missed Diagnoses: What Gets Confused With Polycystic Ovary Syndrome
PCOS affects 6 to 12% of reproductive-age women yet takes an average of 2 years and 3 clinicians to diagnose correctly. Learn which conditions mimic PCOS, which PCOS-related conditions get missed, and how the 2023 international guidelines changed the diagnostic framework.
PCOS (Polycystic Ovary Syndrome): When to Seek a Second Opinion
A guide to recognizing when your PCOS diagnosis or treatment plan needs a second look, with evidence-based thresholds, named trials, and society guidelines.
PCOS Treatment Failure: What Counts and What to Do Next
A guide to defining PCOS treatment failure by domain, ovulation induction, metabolic targets, and androgen control, with evidence-based timelines and a framework for confirming failure before escalating care.
Perimenopause Stopping Treatment Safely: A Clinical Guide
Learn how to stop perimenopause treatments safely, including HRT, low-dose oral contraceptives, and non-hormonal therapies. Evidence-based tapering protocols, withdrawal timelines, and society guideline recommendations.
Perimenopause: How to Prep for Your First Visit
A clinical guide to preparing for your first perimenopause appointment. Learn what symptoms to track, which lab tests to expect, and which treatments your doctor may discuss, all backed by major society guidelines.
Perimenopause Commonly Missed Diagnoses: What Doctors Mistake It For
Perimenopause is misdiagnosed as depression, thyroid disease, anxiety, ADHD, and more. Learn which conditions get confused, why labs mislead, and how to get the right diagnosis.
Perimenopause: When to Seek a Second Opinion
A guide covering perimenopause symptoms, treatment options, and the specific signs that mean you need a second medical opinion. Includes real trial data, society guidelines, and decision frameworks.
Perimenopause Treatment Failure: What It Means and What to Do Next
Learn exactly what counts as treatment failure in perimenopause, how to recognize it across HRT, oral contraceptives, and non-hormonal options, and what clinical guidelines say about next steps.
Prediabetes Annual Evaluation Checklist: What to Test, When, and Why
A complete prediabetes annual evaluation checklist covering A1c, fasting glucose, lipids, blood pressure, kidney function, and lifestyle targets, with ADA and USPSTF guideline citations and clinical trial data.
Secondary Hypogonadism First-Line Treatment Decision Framework
A clinician-grade guide to choosing between enclomiphene, hCG, and exogenous testosterone for secondary hypogonadism. Covers diagnosis, fertility goals, guideline recommendations, and monitoring targets.
Secondary Hypogonadism: When to Seek a Second Opinion
A guide on secondary hypogonadism covering diagnosis, management, fertility-preserving alternatives to TRT, and the specific red flags that mean you need a second opinion fast.
Tendinopathy Annual Evaluation Checklist: A Complete Management Guide
A structured annual evaluation checklist for tendinopathy, covering pain scoring, load tolerance, imaging, injection history, and return-to-sport criteria. Drafted by the HealthRX.com medical team for clinician and patient education, pending qualified medical review.
Tendinopathy Emergency Symptoms Requiring 911
Learn which tendinopathy symptoms are true medical emergencies requiring 911, how to distinguish a tendon rupture from chronic tendinopathy, and what conservative and advanced treatments actually work.
Tendinopathy: How to Stop Treatment Safely
A guide on stopping tendinopathy treatment safely, including when to taper load, discontinue injections, and monitor for relapse using evidence-based criteria.
Tendinopathy: When to Seek a Second Opinion
A guide to tendinopathy management and the specific signs that mean your current treatment plan needs a fresh set of eyes. Includes exercise protocols, injection options, and red flags.
Tendinopathy Treatment Failure: What Counts and What Comes Next
Learn exactly when tendinopathy treatment is considered a failure, what criteria clinicians use, and which second-line options have evidence behind them, from eccentric loading to PRP to surgical referral.
Established Cardiovascular Disease: Open Controversies in the Field
A deep dive into the most contested clinical questions in established cardiovascular disease, from optimal LDL targets to the role of GLP-1 agonists, polypharmacy debates, and residual inflammatory risk.
Established Cardiovascular Disease: Global Prevalence and Trends
A overview of established cardiovascular disease worldwide, covering prevalence data, regional burden, mortality trends, and guideline-based risk context for patients and providers.
Racial and Ethnic Disparities in Established Cardiovascular Disease
Cardiovascular treatment gaps by race and ethnicity: primary studies, stroke data, secondary prevention and practical ways to improve access and follow-up.
Established Cardiovascular Disease: Rare and Atypical Presentations
A guide to rare and atypical presentations of established cardiovascular disease, including silent MI, vasospastic angina, Kounis syndrome, cardiac syndrome X, MINOCA, and Takotsubo cardiomyopathy, with an evidence-boundary map and a bedside screening framework.
Male Hypogonadism: History of Treatment Over Decades
A timeline of male hypogonadism treatment from 19th-century organotherapy through modern testosterone formulations, GnRH-based therapies, and emerging peptide research, with an evidence-boundary review of which historical claims are well established and which need verification.
Menopause Global Prevalence and Trends: What the Data Show
A look at how many people experience menopause worldwide, regional age-at-menopause differences, rising life-expectancy implications, and what epidemiological trends mean for treatment planning.
Menopause History of Treatment Over Decades
A clinical timeline of menopause treatment from the 1940s to today, covering estrogen therapy, the WHI trial, and current hormone and non-hormone options with guideline-based guidance.
Menopause Racial and Ethnic Disparities: What the Evidence Shows
Black, Hispanic, Asian, and Indigenous women experience menopause differently from white women across timing, symptom severity, hormone therapy access, and cardiovascular risk. This evidence-based guide explains the gaps and what clinicians should do about them.
Menopause-Related Weight Gain: Global Prevalence and Trends
An evidence-based overview of how common menopause-related weight gain is worldwide, which populations are most affected, and what the data say about body composition shifts during the menopausal transition.
Metabolic Syndrome Emerging Mechanism Research: What the Latest Science Reveals
A deep dive into the emerging mechanisms driving metabolic syndrome, covering gut microbiome dysbiosis, inflammasome activation, mitochondrial dysfunction, epigenetic reprogramming, and adipokine signaling, with primary-source citations throughout.
Metabolic Syndrome Racial and Ethnic Disparities: What the Data Show
A guide to racial and ethnic disparities in metabolic syndrome prevalence, diagnosis, and treatment, with primary-source citations and practical clinical guidance.
Metabolic Syndrome Rare and Atypical Presentations: What Clinicians Miss
A clinical deep-dive into the rare and atypical presentations of metabolic syndrome, including lean MetS, pediatric cases, PCOS overlap, lipodystrophy, and normal-weight obesity. Includes guidelines, trial data, and a decision framework.
NAFLD / MASLD Pediatric vs Adult Differences: Clinical Guide
How NAFLD and MASLD differ between children and adults in histology, risk factors, diagnosis, and treatment. Evidence-based guide with primary citations.
NAFLD / MASLD Socioeconomic Impact: Costs, Productivity Losses, and the Global Burden
A detailed breakdown of the socioeconomic burden of NAFLD/MASLD: healthcare costs, lost productivity, disability, health disparities, and what updated MASLD criteria mean for population-level projections.
Obesity (BMI ≥30) Global Prevalence and Trends
A data-driven overview of how obesity rates have changed worldwide, which populations carry the highest burden, and what current epidemiology means for clinical practice.
Obesity (BMI ≥30) Socioeconomic Impact: Costs, Productivity, and Disparities
A deep dive into the socioeconomic burden of obesity, covering direct medical costs, lost productivity, wage penalties, health disparities, and what current evidence says about reducing that burden.
Obstructive Sleep Apnea (OSA) Global Prevalence and Trends
An evidence-based overview of obstructive sleep apnea global prevalence, regional trends, risk factors, and clinical burden, prepared by the HealthRX.com Editorial Team.
PCOS in Adolescents vs. Adults: Key Diagnostic and Treatment Differences
Polycystic ovary syndrome looks and behaves differently in teenagers than in adult women. This guide explains how symptoms, diagnostic criteria, lab thresholds, and treatment approaches differ by age, with citations to current Endocrine Society and international consensus guidelines.
PCOS Rare and Atypical Presentations: What Clinicians and Patients Often Miss
Beyond the classic triad of irregular periods, hyperandrogenism, and polycystic ovaries, PCOS can appear in ways that delay diagnosis for years. Learn the uncommon phenotypes, diagnostic pitfalls, and evidence-based workup strategies.
Perimenopause Socioeconomic Impact: Costs, Productivity, and the Case for Early Treatment
Perimenopause costs the U.S. Economy billions each year through lost productivity, higher healthcare utilization, and workforce attrition. This evidence-based guide covers the full economic burden, what drives it, and what clinical interventions change the numbers.
Tendinopathy History of Treatment Over Decades
A clinical history of how tendinopathy treatment has evolved from rest and corticosteroids to eccentric loading, biologics, and emerging peptide therapies. prepared by the HealthRX.com Editorial Team.
Tendinopathy Racial and Ethnic Disparities: What the Evidence Shows
A look at how race and ethnicity shape tendinopathy risk, diagnosis rates, treatment access, and outcomes, with primary-source citations throughout.
Tendinopathy Rare and Atypical Presentations: A Clinical Guide
An evidence-based guide to rare and atypical tendinopathy presentations, including fluoroquinolone-induced tendinopathy, calcific variants, systemic disease associations, and bilateral spontaneous ruptures. prepared by the HealthRX.com Editorial Team.
Type 2 Diabetes Rare and Atypical Presentations: What Clinicians and Patients Miss
A clinical deep-dive into the rare and atypical presentations of type 2 diabetes, including euglycemic DKA, latent autoimmune diabetes in adults, ketosis-prone T2D, and more. Includes statistics, guideline quotes, and original frameworks.
Farxiga Sexual Function Impact: What Dapagliflozin Does (and Doesn't Do) to Libido, Erectile Function, and Genital Health
A guide to how dapagliflozin (Farxiga) affects sexual function in men and women with type 2 diabetes, heart failure, and CKD, including trial data, mechanistic explanations, and clinical management of genital mycotic infections.
Why Is Midlife Weight Gain So Hard to Lose?
Hormonal shifts, muscle loss, and metabolic slowdown all converge in midlife to make weight loss genuinely harder. A HealthRX.com clinical breakdown of the mechanisms and evidence-based strategies that actually work.
Trulicity (Dulaglutide) Safety for Adults Ages 50 to 64: What the Evidence Shows
A guide to dulaglutide (Trulicity) safety in adults aged 50, 64, covering cardiovascular outcomes, GI tolerability, hypoglycemia risk, polypharmacy, and the REWIND trial data.
Trulicity (Dulaglutide) Safety in Young Adults Ages 18 to 29
A guide to dulaglutide (Trulicity) safety for young adults ages 18, 29, covering trial evidence, side effects, fertility, contraception, and dosing guidance with primary-source citations.
Trulicity Plateau & Non-Response Troubleshooting: A Clinical Guide
Why dulaglutide (Trulicity) stops working and what to do about it. MD-level plateau troubleshooting covering dose optimization, GLP-1 receptor tachyphylaxis, combination strategies, and switch protocols backed by primary trial data.
Trulicity Pre-Surgery Hold Window: When to Stop Dulaglutide Before an Operation
Evidence-based guidance on how long to hold dulaglutide (Trulicity) before surgery, why delayed gastric emptying raises aspiration risk, and how to manage blood glucose in the perioperative period.
Trulicity Renal Protection or Renal Risk: What the Evidence Actually Shows
A physician-level review of dulaglutide's effects on kidney function, including REWIND trial data, GFR trajectories, albuminuria outcomes, and clinical guidance for patients with CKD.
Dutasteride (Avodart) Monitoring in Adolescents Ages 12 to 17
A clinician-focused guide to dutasteride (Avodart) monitoring protocols for adolescents aged 12, 17, covering growth, hormonal, psychiatric, and laboratory checkpoints with evidence-based dosing context.
Avodart Cognitive Function Impact: What the Evidence Actually Shows
An evidence-based look at dutasteride (Avodart) and cognitive function, covering neurosteroid pathways, clinical trial data, risk stratification, and what patients should discuss with their prescribers.
Avodart Metabolism and Energy Expenditure: What the Evidence Actually Shows
A deep dive into how dutasteride (Avodart) is metabolized, how it affects androgen-driven thermogenesis, and what clinicians and patients need to know about energy expenditure changes on long-term therapy.
Avodart (Dutasteride) After Bariatric Surgery: What Patients and Clinicians Need to Know
A clinical guide to dutasteride (Avodart) use after bariatric surgery, covering altered pharmacokinetics, absorption concerns, dosing strategies, and hair-loss treatment evidence in post-bariatric patients.
Avodart Renal Protection or Renal Risk: What the Evidence Actually Shows
A clinical deep-dive into dutasteride (Avodart) and kidney health: does it protect the kidneys, harm them, or neither? Evidence from primary trials, pharmacokinetic data, and clinical guidelines prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Adult (30-49) Dosing: Complete Clinical Guide
Evidence-based dosing guide for enclomiphene citrate in men aged 30-49 with secondary hypogonadism. Covers starting doses, titration, monitoring, and clinical trial data prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Dosing for Older Adults (Ages 50 to 64)
A guide to enclomiphene citrate dosing in the 50, 64 age group, covering starting doses, titration, monitoring labs, cardiovascular considerations, and how older-adult physiology changes the risk-benefit calculation.
Enclomiphene Citrate Pediatric (Under 12) Dosing: What Clinicians and Parents Need to Know
A comprehensive clinical review of enclomiphene citrate dosing considerations for children under 12, covering FDA labeling status, off-label use rationale, safety monitoring, and the absence of pediatric trial data.